MedKoo Biosciences

About us  |  Services  |  Products  |  News  |  Careers  |  Contact us

 

 

 


 

Back to products

 

 Browse products

Approved anticancer agents

Anticancer agents in trials

Anticancer agents in preclinical trials

Anticancer molecular libraries

 


Other drug agents

Drug intermediates

Bio-reagents and biochemicals

 

 

 

 

 

 

 

 

MedKoo product information:

Omtriptolide

MedKoo Code#:  200385

Name:  Omtriptolide

CAS#:  195883-06-8 (Omtriptolide); 195883-09-1 (Omtriptolide sodium)

 

Synonym:   PG490-88Na. Chemical name: ***Butanedioic acid, mono[(3bS,4aS,5aR,6R,6aS,7aS,7bS,8aS,8bS)-1,3,3b,4,4a,6,6a,7a,7b,8b,9,10-
dodecahydro-8b-methyl-6a-(1-methylethyl)-1-oxotrisoxireno[4b,5:6,7:8a,9]phenanthro[1,2-c]furan-6-yl] ester, sodium salt;     ***sodium 4-[(3bS,4aS,5aR,6R,6aS,7aS,7bS,8aS,8bS)-8b-methyl-6a-(1-methylethyl)-1-oxo-1,3,3b,4,4a,6,6a,7a,7b,8b,9,10-dodecahydrotrisoxireno[4b,5:6,7:8a,9]phenanthro[1,2-c]furan-6-yl]-4-oxobutanoate.

 

IUPAC/Chemical name: 

 

 

Chemical structure:

Theoretical analysis:
Chemical Formula: C24H27NaO9
Molecular Weight: 482.45
Elemental Analysis: C, 59.75; H, 5.64; Na, 4.77; O, 29.85

 

Availability and price:

This agent is not in stock, which may be available through custom synthesis. To inquire quotation and lead time or to ask questions, please send email to sales@medkoo.com to describe your needs. A representative will respond your email shortly. We offer big discount for orders of bulk quantities.

 

 

Information about this agent

PG490-88 is a semisynthetic derivative of the novel compound PG490 (triptolide) purified from a Chinese herb. It has been shown to prolong acute allograft survival in multiple experimental organ transplant models. However, the effect of PG490-88 on prevention of acute and chronic renal allograft rejection has not been determined. Kidneys of ACI or F344 rats were transplanted into bilaterally nephrectomized LEW recipients as the acute or chronic allograft rejection models, respectively. Treatment of LEW recipients with PG490-88 significantly prolonged ACI kidney graft survival in a dose-dependent manner when compared with the untreated allograft controls. LEW recipients of F344 kidney grafts who received PG490-88 for 90 days with a brief course of low-dose FK506 showed normal serum creatinine levels and markedly reduced histological changes of chronic rejection at day 90 after transplantation. These results suggest that PG490-88 significantly prolongs kidney allograft survival in an acute rejection model and prevents chronic allograft rejection in rats. See: Transplant Proc. 2005 Jan-Feb;37(1):134-6. http://www.ncbi.nlm.nih.gov/pubmed/15808572.

 

Current developer:    Pharmagenesis

 

References

 1: Chen G, Sun H, Arp J, Garcia B, Wang X, Wise Y, Liu W, Ramcharran S, Huang X, Xiang Y, Yang H, Fang Z, Madrenas J, Sudo Y, Tamura K, Zhong R. A synergistic effect between PG490-88 and tacrolimus prolongs renal allograft survival in monkeys. Am J Transplant. 2006 Apr;6(4):714-23. Erratum in: Am J Transplant. 2006 Jun;6(6):1498. Madenas, J [corrected to Madrenas, J]. PubMed PMID: 16539628.

2: Wang X, Sun H, Chen G, Liu W, Wise Y, Yung C, Sudo Y, Tamura K, Garcia B, Zhong R. Immunosuppression with a combination of pg490-88 and a subtherapeutic dose of FK506 in a canine renal allograft model. Transplantation. 2005 Jun 15;79(11):1537-44. PubMed PMID: 15940043.

3: Fisniku O, Pan F, Wynn C, Erickson LM, Crews G, Jang MS, Sudo Y, Tamura K, Kobayashi M, Benediktsson H, Jiang H. Protective effects of PG490-88 on chronic allograft rejection by changing intragraft gene expression profiles. Transplant Proc. 2005 May;37(4):1962-4. PubMed PMID: 15919518.

4: Crews GM, Erickson L, Pan F, Fisniku O, Jang MS, Wynn C, Benediktsson H, Kobayashi M, Jiang H. Down-regulation of TGF-beta and VCAM-1 is associated with successful treatment of chronic rejection in rats. Transplant Proc. 2005 May;37(4):1926-8. PubMed PMID: 15919506.

5: Pan F, Fisniku O, Wynn C, Erickson LM, Crews G, Jang MS, Sudo Y, Tamura K, Kobayashi M, Benediktsson H, Jiang H. PG490-88, a new immunosuppressant, effectively prevents acute and chronic rejection in rat renal allografts. Transplant Proc. 2005 Jan-Feb;37(1):134-6. PubMed PMID: 15808572.

6: Fidler JM, Li K, Chung C, Wei K, Ross JA, Gao M, Rosen GD. PG490-88, a derivative of triptolide, causes tumor regression and sensitizes tumors to chemotherapy. Mol Cancer Ther. 2003 Sep;2(9):855-62. PubMed PMID: 14555704.

7: Leonard CT, Soccal PM, Berry GJ, Doyle RL, Theodore J, Duncan SR, Rosen GD. PG490-88, a derivative of triptolide, attenuates obliterative airway disease in a mouse heterotopic tracheal allograft model. J Heart Lung Transplant. 2002 Dec;21(12):1314-8. PubMed PMID: 12490278.

8: Fidler JM, Ku GY, Piazza D, Xu R, Jin R, Chen Z. Immunosuppressive activity of the Chinese medicinal plant Tripterygium wilfordii. III. Suppression of graft-versus-host disease in murine allogeneic bone marrow transplantation by the PG27 extract. Transplantation. 2002 Aug 27;74(4):445-57. PubMed PMID: 12352901.

9: Kiviharju TM, Lecane PS, Sellers RG, Peehl DM. Antiproliferative and proapoptotic activities of triptolide (PG490), a natural product entering clinical trials, on primary cultures of human prostatic epithelial cells. Clin Cancer Res. 2002 Aug;8(8):2666-74. PubMed PMID: 12171899.

10: Chen BJ, Chen Y, Cui X, Fidler JM, Chao NJ. Mechanisms of tolerance induced by PG490-88 in a bone marrow transplantation model. Transplantation. 2002 Jan 15;73(1):115-21. PubMed PMID: 11792990.

11: Krishna G, Liu K, Shigemitsu H, Gao M, Raffin TA, Rosen GD. PG490-88, a derivative of triptolide, blocks bleomycin-induced lung fibrosis. Am J Pathol. 2001 Mar;158(3):997-1004. PubMed PMID: 11238047; PubMed Central PMCID: PMC1850337.

12: Chen BJ, Liu C, Cui X, Fidler JM, Chao NJ. Prevention of graft-versus-host disease by a novel immunosuppressant, PG490-88, through inhibition of alloreactive T cell expansion. Transplantation. 2000 Nov 27;70(10):1442-7. PubMed PMID: 11118087.

13: Wang J, Xu R, Jin R, Chen Z, Fidler JM. Immunosuppressive activity of the Chinese medicinal plant Tripterygium wilfordii. I. Prolongation of rat cardiac and renal allograft survival by the PG27 extract and immunosuppressive synergy in combination therapy with cyclosporine. Transplantation. 2000 Aug 15;70(3):447-55. PubMed PMID: 10949186.

 

 

Contact MedKoo:

Email: sales@medkoo.com

 

(Keyword; CAS#; MedKoo code#)

 

 

 

 

 

 

 

About us  |  Services  |  Products  |  News  |  Careers  |  Contact us

© MedKoo Biosciences. All Rights Reserved